Cited by 4Medicinal Plants and NeuroprotectionMedicinal Plant ResearchGinkgo biloba and Cashew Applications

Neuroprotective and antioxidant activities of fraction isolated from methanolic extract of Sapindus laurifolia on scopolamine induced dementia

Open access
Bandaru, Nagaraju, Ramu, A, Vidhyadhara, S·2020·Pharmacognosy Research

Abstract

Background: Phytotherapy is considered a complementary approach for preventing and treating many diseases.Plants are rich source of bioactive secondary metabolites of a wide variety such as saponins, tannins, terpenoids, alkaloids, and flavonoids.Sapindus laurifolia (fam: Sapindaceae), well known as soapnuts, are used medicinally as an expectorant, emetic, contraceptive, and for treatment of excessive salivation, epilepsy, chlorosis, and migraines.Objective: To isolation of fractions, estimation of total flavonoid content, in vitro antioxidant and in vivo neuroprotective activity of S. laurifolia fruit kernel.Materials and Methods: In this study, in vitro antioxidant activity is estimated by 2,2-diphenyl-1-picrylhydrazyl assay method.Neuroprotective activity is estimated by scopolamine-induced dementia method.In neuroprotective method, behavioral parameters were checked by escape latency (EL) time (s) by using the Morris water maze, active avoidance testing using elevated plus maze, and neurochemicals such as glutathione, catalase (CAT), superoxide dismutase (SOD), and Cholinesterase were estimated.Results: In scopolamine-induced dementia, increased EL time, active avoidance and neurochemicals such as glutathione, CAT, SOD and cholinesterase decreased.Whereas standard and Fraction S-treated animals decreased in EL time, active avoidance and increased locomotor activity, neurochemicals such as glutathione, CAT, SOD, and cholinesterase also increased.Conclusion: The present study clearly demonstrates that methanolic extract of S. laurifolia Fraction A (50 and 100 mg/kg) kernel significantly attenuate scopolamine-induced dementia by improving the learning, memory, antioxidant potentiality, and anti-acetyl cholinesterase activity.Therefore, this Fraction A can be a potential novel therapeutic strategy for controlling neurodegenerative dementia especially Alzheimer's disease.Yet, advance studies are needed to characterize the active compound(s) and expose the possible mechanism of action.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/pr.pr_50_19

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 31 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. Hossain MS, Asaduzzaman M, Uddin MS, Noor MA, Rahman MA Munira MS, et al. Investigation of the in vitro antioxidant and cytotoxic activities of Xanthosoma sagittifolium leaf. Adv Alzheimer Dis 2016;5:5-3300.
  2. Sharma J, Chawla R, Kumar R, Sharma A, Sharma RK, Arora R. Camellia sinensis as a safe neuroprotective radiation counter measure agent. Int J Pharm Sci Invent 2013;2:26-33.
  3. Ghazouani N, Abderrabba M, Bouajila J. In-vitro evaluation of pharmaceutical activities of Teucriumram osissimum. J Nat Prod 2015;8:106-12.
  4. Sumanth M, Sowmya H, Nagaraj SV, Narasimharaju K. Efficacy of donepezil and galantamine in retrograde amnesia. AJPCR 2010;3:23-5.

Cited by

Sorted by citations

Authors
Bandaru, N., Ramu, A., & Vidhyadhara, S.
Venue
Pharmacognosy Research
Published
2020
Volume
12
Issue
2
Pages
119
ISSN
0974-8490 (ISSN-L)
OpenAlex
W3025682418
Cited by
3
References
31
Citations by year
2024: 1 · 2021: 2
FWCI
0.55
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
Pharmacognosy Research (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
  • Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
Keywords
soapnut, neuroprotective activity, antioxidant activity, scopolamine-induced dementia, Alzheimer's disease, memory impairment, acetylcholinesterase inhibition, cholinesterase, superoxide dismutase, catalase, glutathione, methanol extract, herbal medicine, neurodegenerative diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review